Corin US revenue unlikely to exceed £10m
Free email from MoneyWeek
Money
Morning is the FREE daily email from MoneyWeek – a punchy round-up
of the latest investment news and profit opportunities. DON’T MISS
IT!
This genius investor does dizzying levels of research to uncover...Half Price Shares!
Corin said full-year revenues from its US business are unlikely to be more than £10m after partner Stryker said it will not buy any further instrumentation and implants from the group until December.
"The lower level of anticipated sales to Stryker in 2008 is clearly disappointing but we, as does Stryker, remain confident that the potential for Cormet in the world's largest orthopaedic market is substantial," said chief executive Peter Huntley.
(Article continues below)Advertisement
The orthopaedic devices firm added that its business outside of the US has continued to trade in line with expectations.
FREE! For all our latest advice on making profitable investments, claim your 3-week FREE trial of the MoneyWeek website and magazine now.
Money Morning is the FREE daily email from MoneyWeek
– a punchy round-up of the latest investment news and profit opportunities.
DON’T MISS IT!
